News from highland therapeutics inc

Apr 28, 2014, 08:05 ET

Highland Therapeutics announces initiation of Phase III trial for HLD-200 in pediatric ADHD patients

TORONTO, April 28, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that its wholly...

Feb 25, 2014, 08:01 ET

Highland Therapeutics to Present at Cowen and Company Healthcare Conference

TORONTO, Feb. 25, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that the...

Nov 27, 2013, 14:28 ET

Highland Therapeutics to Present at Piper Jaffray Healthcare Conference

TORONTO, Nov. 27, 2013 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that the...

Oct 03, 2013, 10:04 ET

Highland Therapeutics Announces Positive Interim Results From Phase I/II Study of HLD-200 in ADHD Patients

TORONTO, Oct. 3, 2013 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a specialty pharmaceutical company leveraging its proprietary...

Aug 15, 2013, 11:10 ET

Highland Therapeutics Announces Closing of US$6.7 Million Financing

- Provides resources for up to five clinical programs planned for 2013, including studies in pediatric and adolescent ADHD patient...

Jun 25, 2013, 08:05 ET

Highland Therapeutics Announces Positive Clinical Results for HLD-200 - A Novel ADHD Therapeutic

- Positive results achieved in Phase 1 HLD-200 study ; confirm second pipeline product - Results further validate Highland's...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
Investor-Edge